(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester
(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester Basic information
- Product Name:
- (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester
- Synonyms:
-
- (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester
- (3aR,4S,7aR)-Methyl 4-hydroxy-4-(2-M-tolylethynyl)-octahydroindole-1-carboxylate
- Mavoglurant
- AFQ 056
- Mavoglurant, AFQ056
- UNII-GT0I9SV4F6; AFQ056; MAVOGLURANT; SURECN989279; GT0I9SV4F6; CHEMBL3087515; AFQ 056; AFQ-056
- CHEMBL3087515
- GT0I9SV4F6
- CAS:
- 543906-09-8
- MF:
- C19H23NO3
- MW:
- 313.39
- Mol File:
- 543906-09-8.mol
(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester Chemical Properties
- Melting point:
- 119 - 121°C
- Boiling point:
- 476.3±45.0 °C(Predicted)
- Density
- 1.21
- storage temp.
- 2-8°C
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 12.75±0.20(Predicted)
- form
- Solid
- color
- White to Off-White
- InChI
- InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1
- InChIKey
- ZFPZEYHRWGMJCV-ZHALLVOQSA-N
- SMILES
- N1(C(OC)=O)[C@@]2([H])[C@]([H])([C@](O)(C#CC3=CC=CC(C)=C3)CCC2)CC1
(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester Usage And Synthesis
Uses
Mavoglurant is a non-competitive metabotropic glutamate receptor 5 (mGlu5) receptor antagonist.
Biological Activity
Orally active, potent and selective mGluR5 antagonist.
AFQ056 (Mavoglurant) is an orally active, potent and selective antagonist of metabotropic glutamate receptor 5 (mGluR5). AFQ056 was investigated for treatment of fragile X syndrome and for Parkinsonμs disease.
in vivo
Mavoglurant (0.1-10 mg/kg; a single p.o.) inhibits the stress-induced hyperthermia (SIH) in a dose-dependent manner in mice[1].
Mavoglurant (9.4 mg/kg; a single p.o.) exhibits moderate oral bioavailability (32%), terminal half-life (2.9 h) and Cmax (plasma; brain) (950 pmol/mL; 3500 pmol/g)[1].
Mavoglurant (3.1 mg/kg; a single i.v.) exhibits terminal half-life (0.69 h), Cmax (plasma; brain) (3330 pmol/mL; 8400 pmol/g) and Tmax (≤0.08 h)[1].
| Animal Model: | Male OF1/IC mice[1] |
| Dosage: | 0.1, 1, 10 mg/kg |
| Administration: | A single p.o. administration |
| Result: | Attenuated the stress-induced hyperthermia. Was comparable to the positive control Chlordiazepoxide. |
| Animal Model: | Male Sprague-Dawley rats (175-250 g)[1] |
| Dosage: | 3.1 mg/kg for i.v.; 9.4 mg/kg for p.o. (Pharmacokinetic Analysis) |
| Administration: | A single i.v. or p.o. administration |
| Result: | P.o.: F=32%; T1/2=2.9 h; Tmax≤0.25 h. I.v.: T1/2=0.69 h; Cmax (plasma/brain)=3330 pmol?mL-1/8400 pmol?g-1; Tmax≤0.08 h. |
IC 50
mGluR5: 30 nM (IC50)
(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl esterSupplier
- Tel
- 17702719238 18971495150;
- sales@sun-shinechem.com
- Tel
- 22-58627059 13920586291
- zdcomcon@126.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com